wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 151 - 200 of 300.

Medicine/Pharmacology - Life Sciences
27.01.2017
Spin-off Cellestia Biotech raises CHF 8 million in seed financing
Spin-off Cellestia Biotech raises CHF 8 million in seed financing
Cellestia Biotech, an EPFL spin-off, can now carry out clinical trials on its new cancer treatment after raising CHF 8 million in seed money.
Life Sciences - Medicine/Pharmacology
26.01.2017
LSD alters perception via serotonin receptors
Humans perceive everyday things and experiences differently and attach different meaning to pieces of music, for instance. In the case of psychiatric disorders, this perception is often altered. For patients suffering from addictions, for instance, drug stimuli are more meaningful than for people without an addiction.
Astronomy
26.01.2017
How fast is the universe expanding? Quasars provide an answer
How fast is the universe expanding? Quasars provide an answer
The H0LiCOW collaboration, a cosmology project led by EPFL and Max Planck Institute and regrouping several research organizations in the world has made a new measurement of the Hubble constant, which indicates how fast the universe is expanding. The new measurement challenges some of the most recent ones, potentially pointing towards new physics beyond the standard cosmological model.
Medicine/Pharmacology
26.01.2017
Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery
Innovative AcrySof IQ PanOptix Toric i ntraocular lens (IOL) extends Alcon's trifocal PanOptix IOL portfolio to a wider range of patients   CE-marked in November 2016, this IOL offers excellent near
Medicine/Pharmacology - Environment/Sustainable Development
26.01.2017
Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report
Novartis Access-to-medicine programs reached approximately 52 million patients, including first-year deliveries through the innovative Novartis Access program   Novartis improved position in key sust
Physics/Materials Science - Business/Economics
26.01.2017
‘Additive Manufacturing' speeds up
‘Additive Manufacturing’ speeds up
Empa offers Switzerland a platform to exchange information and knowhow in the field of Additive Manufacturing: During a technology briefing held at Empa Academy on January 18, experts from industry a
Medicine/Pharmacology - Business/Economics
26.01.2017
Inability to Work: Medical Experts Often Disagree
Independent medical evaluations are often used to adjudicate disability claims. But different doctors assessing the same patient often disagree on whether the patient is disabled or not. This problem can be mitigated by applying standardized procedures, says an international study led by researchers at the University of Basel and the University Hospital Basel in Switzerland.
Social Sciences
26.01.2017
‘We need a decentralisation of the Internet'
‘We need a decentralisation of the Internet’
Tim Berners-Lee, the father of the World Wide Web, has had a substantial impact on our lives. While his invention was a resounding success and the Internet has developed unexpectedly fast, he is anything but satisfied with today's situation.
Business/Economics - Medicine/Pharmacology
25.01.2017
Novartis delivered solid 2016 performance, with Growth Products[1] absorbing Gleevec US LOE; innovation momentum continued; announces share buyback
Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback FY net sales (0% cc ) in line with prior year due to st
Earth Sciences - Physics/Materials Science
23.01.2017
Chronicle of a catastrophic landslide
Chronicle of a catastrophic landslide
Dramatic developments have been documented at the Aletsch glacier, where the ice has retreated at such a pace that an adjoining slope has also started to move rapidly. With the help of a unique dataset, researchers are able to demonstrate a direct connection between the ice loss of the Aletsch glacier and the slippage of the Moosfluh slope.
Physics/Materials Science - Chemistry
23.01.2017
Higher methane yield from bio-waste
Higher methane yield from bio-waste
Within Switzerland's bio-waste a huge amount of precious energy is hidden. That's because valuable methane, the main constituent of natural gas, can be obtained from it.
Life Sciences - Medicine/Pharmacology
23.01.2017
Immune Defense Without Collateral Damage
Immune Defense Without Collateral Damage
Researchers from the University of Basel in Switzerland have clarified the role of the enzyme MPO. In fighting infections, this enzyme, which gives pus its greenish color, produces a highly aggressive acid that can kill pathogens without damaging the surrounding tissue. In the human body's fight against bacterial pathogens, white blood cells are in the front line.
Life Sciences - Medicine/Pharmacology
20.01.2017
Cell fate regulation by LIN41: activity determined by binding location
Helge Großhans and his group at the Friedrich Miescher Institute for Biomedical Research (FMI) have elucidated the mode of action of the RNA-binding protein and stem cell factor LIN41. In an animal model, they showed that LIN41 silences four specific mRNAs, by two distinct mechanisms. They found that the choice of mechanism is determined by where on the mRNA LIN41 binds.
Environment/Sustainable Development - Chemistry
19.01.2017
Hot on the heels of cement's formulae
Hot on the heels of cement’s formulae
Bridges, houses, dams - for decades, cement has been a permanent feature of our urban environment. What is deemed a robust and lasting material, however, is actually fragile and highly complex on the inside.
Architecture - History/Archeology
19.01.2017
Bringing energy-hungry buildings up to date
Bringing energy-hungry buildings up to date
As buildings evolve from energy consumers to energy producers, architecture is seeing a major paradigm shift, with building renovations becoming a real challenge.
Microtechnics/Electroengineering - Computer Science/Telecom
18.01.2017
ETH Zurich at WEF 2017 in Davos: ‘Magic through Technology'
ETH Zurich at WEF 2017 in Davos: ‘Magic through Technology’
ETH Zurich is presenting its latest research findings in a public exhibition at the World Economic Forum 2017.
Computer Science/Telecom
17.01.2017
Work in the year 2050
Work in the year 2050
How will digitalisation, artificial intelligence and robotics change the world of work? This question was discussed by numerous experts from business and academia at the ‘Global Talent Summit' before an audience of more than 300 in the Audi Max room at ETH Zurich.
Medicine/Pharmacology - Life Sciences
17.01.2017
On track to heal leukaemia
On track to heal leukaemia
Media releases, information for representatives of the media Media Relations (E) The first clinical studies for a new type of immunotherapy for leukaemia are beginning at Bern's University Hospital and the Department of Clinical Research (DCR) of the University of Bern. Antibodies discovered in the laboratory should inhibit the growth of tumour cells.
Medicine/Pharmacology - Life Sciences
16.01.2017
Every Meal Triggers Inflammation
When we eat, we do not just take in nutrients - we also consume a significant quantity of bacteria. The body is faced with the challenge of simultaneously distributing the ingested glucose and fighting these bacteria.
Social Sciences - Earth Sciences
13.01.2017
Bhutan's happiness stems from its hydropower too
Bhutan's happiness stems from its hydropower too
EPFL researchers are supporting this Himalayan country's efforts to expand its hydropower capacity. At a time when dams in Switzerland are up for sale, another small mountainous country intent on preserving its natural environment is looking to further tap into its hydroelectric potential.
Environment/Sustainable Development - Media
12.01.2017
Peter Messerli named co-chair of UN Global Sustainable Development Report
Peter Messerli named co-chair of UN Global Sustainable Development Report
Media releases, information for representatives of the media Media Relations (E) Peter Messerli, Professor of Sustainable Development at the University of Bern, has been selected as co-chair to lead
Physics/Materials Science - Chemistry
12.01.2017
Creating the tiniest structures on
Creating the tiniest structures on
Nanotechnology is regarded as the key technology of the 21 st century, delivering the fundamental methods, which allow objects just a few hundred nanometers in size to be produced in any required shape.
Physics/Materials Science - Environment/Sustainable Development
10.01.2017
Summer heat for the winter
Summer heat for the winter
Can thermal solar energy be stored until wintertime? Yes, this is possible, using a cheap material like sodium lye.
Medicine/Pharmacology - Life Sciences
09.01.2017
New insights into mechanisms of breast cancer development and resistance to therapy
Why does breast cancer develop and how come certain patients are resistant to established therapies' Researchers from the University of Basel have gained new insights into the molecular processes in breast tissue. They identified the tumor suppressor LATS as a key player in the development and treatment of breast cancer.
Life Sciences - Medicine/Pharmacology
06.01.2017
Medicine/Pharmacology - Life Sciences
06.01.2017
Novartis invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders
Novartis enters into an exclusive option agreement with Ionis and Akcea to license two investigational treatments expected to significantly reduce cardiovascular risk in patients living with elevated
Life Sciences - Medicine/Pharmacology
06.01.2017
Autoimmunity and Infections: When the Body Fights Itself
Basel-based doctors are on the trail of a possible connection between autoimmune diseases and infections: errors can occur when immune cells absorb certain proteins from pathogen cells. These It is already known that there is a connection between infections and autoimmunity – the inability of an organism to recognize parts of its own body as “self”.
Medicine/Pharmacology - Physics/Materials Science
03.01.2017
Looking back at 2016 (2/2)
Looking back at 2016 (2/2)
Slowing the aging process, improving data security, enabling paraplegics to walk again, transporting vaccines at room temperature to warm countries, creating jobs with the CHF 400 million raised by spin-offs - those are just some of the many areas where EPFL scientists have made a lasting contribution.
Chemistry - Physics/Materials Science
03.01.2017
Chemically Modified Insulin Is Available More Quickly
Chemically Modified Insulin Is Available More Quickly
Replacing a hydrogen atom by an iodine atom in insulin, the hormone retains its efficacy but is available more rapidly to the organism. Researchers at the University of Basel were able to predict this effect based on computer simulations and then confirm it with experiments. Insulin is formed in the pancreas and regulates the blood glucose level.
Life Sciences - Medicine/Pharmacology
27.12.2016
Looking back at 2016 (1/2)
Looking back at 2016 (1/2)
Health, energy, maths and chocolate: no field of research has been neglected last year by EPFL's scientists.  Cheaper solar cells with 20.2% efficiency Some of the most promising solar cells today use light-harvesting films made from perovskites. However, perovskite-based solar cells use expensive ‘hole-transporting' materials, whose function is to move the positive charges that are generated when light hits the perovskite film.
Microtechnics/Electroengineering - Computer Science/Telecom
23.12.2016
A world record followed by a world premiere
A world record followed by a world premiere
A new world record for acceleration, a timber roof built by construction robots, and a unique competition for people with disabilities: in 2016, research and campus life at ETH Zurich were dominated by innovation and premieres.
Medicine/Pharmacology - Life Sciences
23.12.2016
Treating cancer with drugs for diabetes and hypertension
Treating cancer with drugs for diabetes and hypertension
A combination of a diabetes medication and an antihypertensive drug can effectively combat cancer cells. The team of researchers led by Prof. Michael Hall at the Biozentrum of the University of Basel has also reported that specific cancer cells respond to this combination of drugs. The results of the study have now been published in ‘Science Advances'.
Medicine/Pharmacology - Environment/Sustainable Development
23.12.2016
Fighting cholera by predicting how its spreads
Fighting cholera by predicting how its spreads
In October, EPFL and Médecins Sans Frontières joined forces in an unprecedented effort to predict how the cholera epidemic in Haiti will spread.
Psychology - Medicine/Pharmacology
22.12.2016
Helping pays off: People who care for others live longer
Older people who help and support others live longer. These are the findings of a study published in the journal ‘Evolution and Human Behavior', conducted by researchers from the University of Basel, Edith Cowan University, the University of Western Australia, the Humboldt University of Berlin, and the Max Planck Institute for Human Development in Berlin.
Medicine/Pharmacology
22.12.2016
Roche’s emicizumab for haemophilia A meets primary endpoint in phase III study
Roche's emicizumab for haemophilia A meets primary endpoint in phase III study Emicizumab prophylaxis reduced the number of bleeds over time compared to no prophylaxis in people with haemophilia A an
Civil Engineering/Traffic Engineering - Chemistry
21.12.2016
A unique additive for the ideal concrete
A unique additive for the ideal concrete
Whether it's for drying time, hardness, or uniformity, a new additive developed at EPFL can give concrete, mortar, and cement the desired consistency, all in one shot.
Medicine/Pharmacology - Life Sciences
21.12.2016
Positive Phase III results for Roche’s investigational medicine OCREVUS (ocrelizumab) published in New England Journal of Medicine
Positive Phase III results for Roche's investigational medicine OCREVUS (ocrelizumab) published in New England Journal of Medicine OCREVUS is the first and only investigational medicine to show superior efficacy versus comparators in both relapsing and primary progressive multiple sclerosis in clinical studies OCREVUS demonstrated a favourable safety profile in three large Phase III studies Roche announced today that data from three Phase III st
Environment/Sustainable Development - Earth Sciences
20.12.2016
Three months in the Antarctic to unlock the secrets of our climate
Three months in the Antarctic to unlock the secrets of our climate
The Antarctic Circumnavigation Expedition (ACE), the first project run by the Swiss Polar Institute (SPI), will set sail this evening from South Africa.
Environment/Sustainable Development - Life Sciences
20.12.2016
University of Zurich to become global center for biodiversity research
University of Zurich to become global center for biodiversity research
Prof. Michael Schaepman, PhD Department of Geography University of Zurich Phone +41 44 635 51 60 E-mail Prof. Bernhard Schmid, PhD Institute of Evolutionary Biology and Environmental Studies
Life Sciences - Administration/Government
20.12.2016
Medicine/Pharmacology - Business/Economics
20.12.2016
Novartis bolsters ophthalmology pipeline through acquisition of Encore Vision, Inc
Novartis confirms its leadership in ophthalmology by entering a new therapy area. Acquisition of Encore Vision, Inc.
Medicine/Pharmacology - Life Sciences
19.12.2016
Novartis announces exclusive option, collaboration and license agreement with Conatus to develop new oral treatments for chronic liver diseases
Novartis announces exclusive option, collaboration and license agreement with Conatus to develop new oral treatments for chronic liver diseases Novartis to broaden liver portfolio to deliver best-in
Architecture - Computer Science/Telecom
19.12.2016
The lab that's betting on low-tech
From the Saint Loup Chapel in Pompaples to the soon-to-be-completed Vidy Theatre Pavilion in Lausanne, the lab run by Yves Weinand is developing new innovations based on an age-old material: wood.
Business/Economics
16.12.2016
Switzerland ratifies Croatia protocol
Bern, 16.12.2016 - Switzerland has ratified the protocol extending the free movement of persons to Croatia.
Medicine/Pharmacology - Life Sciences
16.12.2016
Novartis drug Votubia recommended by CHMP for EU approval to treat refractory partial-onset seizures in patients with TSC
If approved, Votubia would be the first adjunctive treatment specifically for refractory seizures in children and adults with tuberous sclerosis complex (TSC)   Seizures are the most common TSC-relat
Medicine/Pharmacology - Life Sciences
16.12.2016
Novartis receives positive CHMP recommendation for Ilaris to treat rare diseases in adults and children called Periodic Fever Syndromes
Periodic Fever Syndromes are rare diseases mostly affecting children and cause recurrent and disabling fevers with potentially life-threatening complications   Ilaris (canakinumab) is recommended for
Environment/Sustainable Development - Earth Sciences
16.12.2016
A month at sea expanding her horizons and knowledge
A month at sea expanding her horizons and knowledge
EPFL student Oriane Etter and 48 other students from universities around the globe just completed the ACE Maritime University.
Medicine/Pharmacology - Business/Economics
16.12.2016
Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited
Acquisition to add a once-daily oral H 4 receptor antagonist, ZPL389, to treat atopic dermatitis, commonly known as eczema, to the Novartis industry-leading pipeline    Investigational ZPL389 showed a clinically and statistically significant improvement of eczema lesions, leading to a 50% reduction in EASI score compared to placebo after eight weeks of treatment with a favorable safety profile   Eczema is a chronic, inflammatory skin condition a
Environment/Sustainable Development
16.12.2016
A drone that flies (almost) like a bird
A drone has been equipped with feathers to increase its precision during flight. The bio-inspired device can spread or close its wings while flying, making it easier to maneuver and more resistant in high winds.